Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension
The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms.
$Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow$
AI-based CAD assessments dramatically improve vascular surgery outcomes
PAD patients evaluated with HeartFlow's noninvasive FFR_CTAnalysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years.
Even lenient plant-based diets can help older adults live longer
Healthy diets that prioritize plant-based foods were associated with reductions in both all-cause mortality or CVD mortality. Diets do not have to be strictly vegan or vegetarian to make that impact, researchers noted.
Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology
The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.
PAD patients face greater risk of death, complications after a heart attack
PAD and CLI patients who show signs of coronary heart disease may benefit from early treatment, according to a new study of nearly 4 million hospitalizations.

New Analyses Presented At AHA 2017 Show Repatha® (evolocumab) Significantly Reduced Cardiovascular Events In Patients With Peripheral Artery Disease And In Patients With A History Of Heart Attacks

THOUSAND OAKS, Calif., Nov. 13, 2017 — Amgen (NASDAQ:AMGN) today announced five new subgroup analyses from the Repatha® (evolocumab) cardiovascular outcomes study (FOURIER) that showed the addition of Repatha to statin therapy improved clinical outcomes with significant reduction of cardiovascular (CV) events, such as heart attack (also called myocardial infarction or MI) and stroke, in high-risk patients with peripheral artery disease (PAD), and in patients with a history of heart attack.

November 14, 2017

Steroid use linked to early coronary artery disease

The use of anabolic androgenic steroids could be associated with early onset coronary artery disease, according to research presented Nov. 4 at the Brazilian Congress of Cardiology.

November 13, 2017

Instances of cardiac arrest after sex are low, but so are the survival rates

The chances of experiencing sudden cardiac arrest (SCA) after sex are slim, but in those rare cases mortality rates are high, reports a study presented this week at the American Heart Association’s Scientific Sessions symposium.

November 10, 2017

Postmenopausal women face higher risk of CVD, stroke a year after discontinuing hormone therapy

Menopausal women who discontinue hormone therapy are at an increased risk for cardiac and stroke deaths a year after they stop taking estrogen, according to a Finnish study published this month in the journal Menopause.

November 9, 2017

CVD, CKD should be assessed together in HIV-positive patients

HIV-positive patients at predicted risk for cardiovascular disease (CVD) and chronic kidney disease (CKD) are at an even greater risk for CVD and CKD events, according to new research published in PLOS Medicine.

November 9, 2017

Financial stress a risk factor for heart attacks

People under significant financial stress are 13 times more likely to have a heart attack than those with no or minimal financial stress, according to research presented Nov. 9 at the Annual Congress of the South African Heart Association.

November 9, 2017

Air pollution as great a risk as hypertension, obesity, diabetes for CVD

Ingestion of fine particulate matter in polluted air raises the risk of cardiovascular disease (CVD) and mortality just as much as, if not more than, common risk factors such as hypertension, diabetes, dyslipidemia and obesity, according to a large-scale study of 136,094 Seoul, Korea, residents.

November 8, 2017

TCT 2017: 6-month DAPT regimen non-inferior to recommended 12 months in STEMI patients

Six months of dual antiplatelet therapy (DAPT) was found to be non-inferior in ST-elevation myocardial infarction (STEMI) patients to the internationally recommended 12-month regimen in a pioneering trial presented at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) conference in Denver.

November 1, 2017

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Acute Coronary Syndromes

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension

AI-based CAD assessments dramatically improve vascular surgery outcomes

Even lenient plant-based diets can help older adults live longer

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

PAD patients face greater risk of death, complications after a heart attack

Around the web